Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
43.94
+1.44 (3.39%)
Jan 31, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Employees
As of December 31, 2023, Monopar Therapeutics had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees decreased by 2 or -16.67% compared to the previous year.
Employees
10
Change (1Y)
-2
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$647,473
Market Cap
267.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
MNPR News
- 8 days ago - Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PRNewsWire
- 5 weeks ago - Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways - Seeking Alpha
- 6 weeks ago - Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - GlobeNewsWire
- 2 months ago - Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 2 months ago - Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus - Seeking Alpha
- 3 months ago - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - GlobeNewsWire
- 3 months ago - Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock - GlobeNewsWire